Resistance to Penicillin and Cephalosporin and Mortality from Severe Pneumococcal Pneumonia in Barcelona, Spain
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Penicillin-resistant strains of Streptococcus pneumoniae are now found worldwide, and strains with resistance to cephalosporin are being reported. The appropriate antibiotic therapy for pneumococcal pneumonia due to resistant strains remains controversial. METHODS: To examine the effect of resistance to penicillin and cephalosporin on mortality, we conducted a 10-year, prospective study in Barcelona of 504 adults with culture-proved pneumococcal pneumonia. RESULTS: Among the 504 patients, 145 (29 percent) had penicillin-resistant strains of S. pneumoniae (minimal inhibitory concentration [MIC] of penicillin G, 0.12 to 4.0 micrograms per milliliter), and 31 patients (6 percent) had cephalosporin-resistant strains (MIC of ceftriaxone or cefotaxime, 1.0 to 4.0 micrograms per milliliter). Mortality was 38 percent in patients with penicillin-resistant strains, as compared with 24 percent in patients with penicillin-sensitive strains (P = 0.001). However, after the exclusion of patients with polymicrobial pneumonia and adjustment for other predictors of mortality, the odds ratio for mortality in patients with penicillin-resistant strains was 1.0 (95 percent confidence interval, 0.5 to 1.9; P = 0.84). Among patients treated with penicillin G or ampicillin, the mortality was 25 percent in the 24 with penicillin-resistant strains and 19 percent in the 126 with penicillin-sensitive strains (P = 0.51). Among patients treated with ceftriaxone or cefotaxime, the mortality was 22 percent in the 59 with penicillin-resistant strains and 25 percent in the 127 with penicillin-sensitive strains (P = 0.64) The frequency of resistance to cephalosporin increased from 2 percent in 1984-1988 to 9 percent in 1989-1993 (P = 0.002). Mortality was 26 percent in patients with cephalosporin-resistant S. pneumoniae and 28 percent in patients with susceptible organisms (P = 0.89). Among patients treated with ceftriaxone or cefotaxime, mortality was 22 percent in the 18 with cephalosporin-resistant strains and 24 percent in the 168 with cephalosporin-sensitive organisms (P = 0.64). CONCLUSIONS: Current levels of resistance to penicillin and cephalosporin by S. pneumoniae are not associated with increased mortality in patients with pneumococcal pneumonia. Hence, these antibiotics remain the therapy of choice for this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal Pneumonia
AUSTRIAN, R., & GOLD, J. (1964) · Annals of Internal Medicine · doi:10.7326/0003-4819-60-5-759 · Cited by 923
Pneumococcal resistance to antibiotics
Klugman, K. P. (1990) · Clinical Microbiology Reviews · doi:10.1128/cmr.3.2.171 · Cited by 799
Emergence of Multiply Resistant Pneumococci
Jacobs, M. R., Koornhof, H. J., Robins-Browne, R. M., Stevenson, C. M., Vermaak, Z. A., Freiman, I., Miller, G. B., Witcomb, M. A., Isaäcson, M., Ward, J. I., et al. (1978) · New England Journal of Medicine · doi:10.1056/nejm197810052991402 · Cited by 630
Management of Infections Caused by Antibiotic-Resistant Streptococcus Pneumoniae
Wood, A. J. J., Friedland, I. R., & McCracken, G. H. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310607 · Cited by 578
Emergence of Drug-Resistant Pneumococcal Infections in the United States
Breiman, R. F. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510470035031 · Cited by 562
Multiple-Antibiotic-Resistant Pathogenic Bacteria -- A Report on the Rockefeller University Workshop
Tomasz, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199404283301725 · Cited by 418
Pallares, R., Gudiol, F., Liñares, J., Ariza, J., Rufi, G., Murgui, L., Dorca, J., & Viladrich, P. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707023170104 · Cited by 373
Self-citationPneumococcal Disease during HIV Infection: Epidemiologic, Clinical, and Immunologic Perspectives
Janoff, E. N., Breiman, R. F., Daley, C. L., & Hopewell, P. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-314 · Cited by 323
Fenoll, A., Bourgon, C. M., Munoz, R., Vicioso, D., & Casal, J. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.1.56 · Cited by 284
An Epidemic of Pneumococcal Disease in an Overcrowded, Inadequately Ventilated Jail
Hoge, C. W., Reichler, M. R., Dominguez, E. A., Bremer, J. C., Mastro, T. D., Hendricks, K. A., Musher, D. M., Elliott, J. A., Facklam, R. R., & Breiman, R. F. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409083311004 · Cited by 271
Failure of Intensive Care Unit Support to Influence Mortality From Pneumococcal Bacteremia
Hook, E. W. (1983) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1983.03330320053032 · Cited by 262
Marton, A., Gulyas, M., Munoz, R., & Tomasz, A. (1991) · Journal of Infectious Diseases · doi:10.1093/infdis/163.3.542 · Cited by 261
Linares, J., Pallares, R., Alonso, T., Perez, J. L., Ayats, J., Gudiol, F., Viladrich, P. F., & Martin, R. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/15.1.99 · Cited by 248
Self-citationNava, J. M., Bella, F., Garau, J., Lite, J., Morera, M.-A., Marti, C., Fontanals, D., Font, B., Pineda, V., Uriz, S., et al. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.5.884 · Cited by 215
John, C. C. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/18.2.188 · Cited by 204
Muñoz, R., Dowson, C. G., Daniels, M., Coffey, T. J., Martin, C., Hakenbeck, R., & Spratt, B. G. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb01422.x · Cited by 193
Pneumococcal Bacteremia in Adults: Age‐dependent Differences in Presentation and in Outcome
Finkelstein, M. S., Petkun, W., Freedman, M. L., & Antopol, S. C. (1983) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1983.tb06283.x · Cited by 155
Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci
Viladrich, P. F., Gudiol, F., Liñares, J., Rufi, G., Ariza, J., & Pallarés, R. (1988) · The American Journal of Medicine · doi:10.1016/0002-9343(88)90061-7 · Cited by 155
Self-citationAntibiotic-Resistant Pneumococcal Disease in South African Children
Friedland, I. R., & Klugman, K. P. (1992) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1992.02160200042023 · Cited by 153
García-Leoni, M. E., Cercenado, E., Rodeño, P., de Quirós, J. C. L. B., Hernández, D. M., & Bouza, E. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.2.427 · Cited by 111
Cited by
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
(2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-644st · Cited by 5,877
Craig, W. A. (1998) · Clinical Infectious Diseases · doi:10.1086/516284 · Cited by 2,908
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Niederman, M. S., Mandell, L. A., Anzueto, A., Bass, J. B., Broughton, W. A., Campbell, G. D., Dean, N., File, T., Fine, M. J., Gross, P. A., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.7.at1010 · Cited by 2,150
Metadata
- Authors
- Pallares, R., Liñares, J., Vadillo, M., Cabellos, C., Manresa, F., Viladrich, P. F., Martin, R., & Gudiol, F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1995-08-24
- Volume
- 333
- Issue
- 8
- Pages
- 474-480
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2331102377
- Cited by
- 773
- References
- 20
- FWCI
- 47.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.